Ignite Creation Date:
2025-12-24 @ 10:58 PM
Ignite Modification Date:
2025-12-25 @ 8:26 PM
Study NCT ID:
NCT04498169
Status:
COMPLETED
Last Update Posted:
2022-09-15
First Post:
2020-07-31
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Phase 2 Study Evaluating the Safety and Efficacy of Netarsudil Ophthalmic Solution in Patients With Corneal Edema Due to Fuchs Corneal Dystrophy
Sponsor:
Aerie Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-17
Start Date Type:
ACTUAL
Primary Completion Date:
2021-08-11
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-08-11
Completion Date Type:
ACTUAL
First Submit Date:
2020-07-31
First Submit QC Date:
None
Study First Post Date:
2020-08-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-08-10
Results First Submit QC Date:
None
Results First Post Date:
2022-09-01
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-31
Last Update Post Date:
2022-09-15
Last Update Post Date Type:
ACTUAL